News-EN - Page 6

Merck introduces an injectable form of Keytruda, potentially transforming cancer treatment with a two-minute administration. The FDA is reviewing this subcutaneous injection, which matches the efficacy of the current IV format. This new method drastically reduces treatment time from two hours to

Groundbreaking research highlights glutamate as a key driver in liver regeneration, revealing its role beyond neural messaging. Hepatocytes release glutamate following liver injury, activating monocytes that mature into macrophages to aid healing. Glutamate balances with glutamine synthetase to precisely control liver repair,

Unisys launches a Post-Quantum Cryptography (PQC) service to counteract emerging quantum threats. The service assesses vulnerabilities in current systems to enhance digital defenses globally. The urgency stems from the potential of quantum computers compromising existing cryptographic protections. Unisys provides a comprehensive suite

Rina-S, an investigational drug in phase 2 trials, shows promise for advanced ovarian cancer patients with limited treatment options. The drug targets folate receptor alpha (FRα) on malignant cells, sparing healthy tissue. Significant results from the RAINFOL-01 study indicate a 55.6% confirmed

The Weill Cancer Hub East, a collaboration involving Princeton University, The Rockefeller University, Weill Cornell Medicine, and the Ludwig Institute, is pioneering new cancer treatment frontiers. Supported by a $50 million donation from the Weill Family Foundation, the hub focuses on integrating

Stock markets mimic storms: unpredictable with tech companies often caught in the winds. SoundHound AI surged when Nvidia acquired a stake but later plummeted 61% after Nvidia’s divestment. Nvidia’s exit left investors speculating on future collaborations, clouding SoundHound’s vision of a voice

Philippe Laffont of Coatue Management is reshaping investment strategies by focusing on technological innovation, notably AI. He divested from Chipotle Mexican Grill after a significant price rebound, citing risks like inflation and slowed organic growth. Laffont’s focus shifts to Super Micro Computer,

The intersection of artificial intelligence, quantum computing, and biotechnology signals a revolutionary shift in human existence. Autonomous vehicles are becoming more prevalent, transforming transportation with advanced navigation systems and learning capabilities. Biotechnology is reshaping healthcare, with genome editing techniques like CRISPR offering

Qifu Technology Inc. defied market turbulence, rising by 4.84% amidst broader declines in Nasdaq and S&P 500. The rise followed a positive endorsement from Bank of America, raising Qifu’s price target to $52.70, indicative of a 13.6% upside. Qifu plans a $600

Quantum computing is evolving beyond science fiction, with key developments at events like NVIDIA GTC Quantum Day. The intersection of quantum mechanics and AI represents a new frontier, enhancing rather than replacing AI capabilities. Quantum solutions are closer than skeptics think, driven

Character Biosciences has secured $93 million in Series B funding to transform the treatment of degenerative eye diseases, particularly age-related macular degeneration (AMD). AMD affects 1 in 8 individuals over 50 and is a leading cause of blindness among older adults globally.

Jim Cramer highlights NVIDIA Corporation as an exemplar of transformation and resilience in the evolving global economic landscape. NVIDIA is renowned for its groundbreaking graphics processing units and plays a pivotal role in artificial intelligence and autonomous driving innovations. Strong relationships between

Amazon navigates its role in the competitive AI landscape, marked by emerging rival Manus. Manus captures attention with its new general AI agent, touted as a significant leap beyond competitors like ChatGPT. Beijing supports Manus, enhancing its prominence as a key player

The BRCA2 gene is crucial for DNA repair and tumor suppression, with mutations increasing cancer risks. Researchers discovered a complex interaction among BRCA2, RAD51, and PARP1, vital for DNA repair. PARP inhibitors, intended for BRCA2-deficient cancers, might not work as expected due

AI is driving a technological renaissance, transforming industries with opportunities akin to the internet boom. AI heralds exponential growth, revolutionizing sectors from transportation to healthcare with advanced intelligence. Investors are urged to seize this ground-floor opportunity, echoing the early days of the

China’s tech landscape is highly competitive in artificial intelligence, with Tencent’s introduction of the T1 model marking a significant development. The T1 model showcases advanced large-scale reinforcement learning, offering swifter response times and efficient handling of complex text documents. T1’s architecture integrates

The University of Alberta presents significant advancements in cancer therapy through a new nanoparticle formulation of the PNKP compound. Onco-Innovations’ study shows that when this compound is combined with radiation therapy, it effectively targets cancer cells while minimizing damage to healthy tissues.

Apple Inc. is grappling with fierce competition in the AI arena, facing challenges from nimble startups like DeepSeek. DeepSeek’s V3 large language model, released on Hugging Face, showcases superior efficiency and problem-solving capabilities, sparking disruption concerns. The success of open-source AI models

Tesla, led by Elon Musk, is predicted to reach a $5 trillion valuation in the next decade, driven by technological advancements. Autonomous driving is central to Tesla’s strategy, with its Full Self-Driving (FSD) feature paving the way for a future of self-driving

Eric Schwartz joins Quantum Computing Inc. (QCi), bolstering its board with his extensive financial expertise. QCi is at the forefront of integrated photonics, poised to revolutionize AI and cybersecurity with room-temperature quantum machines. Schwartz brings two decades of experience in corporate finance,